Skip to content

DOKTER LOIC SERMEUS

Active
Private limited companyfounded 2023active for 3 yearsLeeuwerikenlaan 61, 1800 Vilvoorde, BelgiumKBO/BCE: BE 0802.587.502
Summary

DOKTER LOIC SERMEUS has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €216,359 and a net result of €90,883. Its solvency ranks better than 53% of 211 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€289,751total assets 2026
Staff
1 FTE
Equity
€216,359
Profit
€90,883
Turnover not published (micro format)
Financial health
97 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 25 days early0 of 1 deed read
Why 97lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.67, cash €243,564Size: total assets €289,751Equity €216,359 (74.7% of total assets)Show the evidence

Checked score

Score 2026
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 76% of its sector peers (NACE 86, micro)
Financial strength · tick = 2025
Strong
Solvency 100+14
equity 74.7% of total assets
Liquidity 90+8
short-term debt 25.3% · cash 84.1%
Profitability 100=
return on assets 31.4%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,058 companies, NACE 86, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.4%▲ +0.1 percentage points vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.5%▲ +0.1 percentage points vs 09-2025highest value 11-2025: < 0.1%▼ -0.5 percentage points vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.67, compared with 2.15 in 2025, above the usual 1.5; short-term debt: 25.3% and cash: 84.1% of total assets), and 25.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 63% on solvency, 75% on liquidity, 80% on profitability and 85% on growth.

The bankruptcy probability was computed on 15-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.67, cash €243,564
NBB · annual accounts
lowers risk · Size: total assets €289,751
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €216,359 (74.7% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 06-10-2026, 25 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2026
25 days early
2025
23 days early
← before the deadline after the deadline →
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
15-10-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · micro…
  2. Equity above €200,000equity €216,359 ▲72.4%
  3. Annual accounts filedfinancial year 2025 · micro…

Key points

  • Positive: Equity rose in 2026from €125,475 to €216,359 ▲ 72.4% View
  • Total assets 20262 financial years filed €289,751 View
  • Active since 2023founded 09-06-2023 3 years View

By topic

Financials

Financial year
2026
Total assets
€289,751
Profit
€90,883
Solvency
74.7%
Total assets▲ 39.7%
Net result
20252026
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
09-06-2023
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.